Skip to main content
  • Login
Home

User account menu

  • Log in

Mega menu

  • EASL
  • Resources

    Resources

    • EASL Resources
      • All Resources
      • Basic Techniques in Experimental Hepatology at a Glance
      • Clinical Practice Guidelines
      • Congress Resources
      • COVID-19 Resources
      • EASL Quiz
      • ePosters
      • Nurses and AHPs
      • Online Courses
      • On-demand Webinars
      • Podcasts
      • Slide Decks
      • Webcasts
      • Webinars Calendar
    • EASL-Related Resources
      • ERN Rare-Liver On-demand Webinars
      • Baveno VII - Consensus Workshop
      • Baveno VII - Pediatric Research Workshop
    • Industry Resources
      • All Resources
      • Industry Symposia - International Liver Congress
      • Industry Symposia - Liver Cancer Summit
      • Industry Symposia - NAFLD Summit 2022
      • Intercept - Primary Biliary Cholangitis: Clinical management
      • Online Course - NASH: From pathogenesis to non-invasive testing
    • Patient Resources
      • All Resources
      • COVID-19 Resources
      • Documents
      • ePosters
      • Infographics
      • Patient Guidelines
      • Podcasts
      • Slide Decks
      • Takeaways
      • Webcasts
  • EASL Studio
  • Journal Club

EASL Quiz

Test Your Guidelines Knowledge
See all quizzes
  • Non-alcoholic fatty liver disease (NAFLD) is characterised by excessive hepatic fat accumulation

    December 2, 2022
  • Epidemiological evidence suggests a tight relationship between unhealthy lifestyle and non-alcoholic fatty liver disease (NAFLD).

    November 18, 2022
  • A 51-year-old woman presents with a Body Mass Index (BMI) < 30 kg/m2

    May 6, 2022
  • A 40-year-old man presents with severe alcohol use disorder (AUD), admitting to heavy episodic drinking as well as binge drinking.

    May 7, 2021
  • Fibrosis is the most important prognostic factor in NAFLD, correlating with liver-related outcomes and mortality.

    Fibrosis is the most important prognostic factor in NAFLD, correlating with liver-related outcomes and mortality. For this reason, the presence of advanced fibrosis is of paramount importance during investigations for NAFLD.
    September 11, 2020
  • A 50-year old man presents with bilateral parotid gland hypertrophy

    How would you screen for harmful alcohol consumption?
    June 19, 2020
EASL.EU Home
Home of Hepatology
7 rue Daubin
1203 Geneva
Switzerland

Follow us:

Sign up to EASL News

©2019 - EASL. All Rights Reserved. Powered by Enovation.

Footer menu

  • Privacy Policy
  • Cookie Policy